Liangjiang enterprise debuts innovative brain-machine product at smart expo

english.liangjiang.gov.cn| Updated: 2025-09-09

Huachuang Shenting (Chongqing) Medical Equipment Co from Liangjiang New Area, Chongqing, in collaboration with Chongqing Boen Fuke Medical Equipment Co, launched their latest AI-powered brain-machine medical product at the World Smart Industry Expo 2025, held from Sept 5 to 8 in the area.

This pioneering technology represents a significant advancement in indigenous brain-machine medical solutions by integrating electromagnetic field bio-detection, non-invasive brainwave detection, neural electrical stimulation, and artificial intelligence.

Cheng Ruogu, chairman of Huachuang Shenting, said that the new technology incorporates four core modules: electromagnetic field bio-detection, brainwave signal decoding, transcranial electrical stimulation, and the Shenting Cloud AI expert system. This comprehensive digital solution covers the entire process from screening to monitoring, rehabilitation, and evaluation.

The technology allows for non-invasive digital detection of early risk signals such as cerebral edema, cerebral hematoma, and multi-regional organic changes. AI algorithms within the expert system aid clinicians in differential interpretation, enhancing diagnostic accuracy.

For cognitive function improvement, the platform utilizes multi-parameter assessments to dynamically adjust transcranial electrical stimulation doses, offering personalized treatment plans. A notable feature is its ability to deliver screening results using simple wearable devices, significantly improving accessibility and convenience.

To support mental health care, the product integrates brain network activity monitoring with closed-loop electrical stimulation, providing clinicians with precise, low-side-effect auxiliary treatment options.

Already implemented in over 1,000 hospitals in the country, the product has collected more than 30 clinical data sets, preliminarily validating its effectiveness and safety in stroke rehabilitation and cognitive impairment intervention scenarios.

Cheng emphasized that the company will continue to foster innovation at the intersection of artificial intelligence and brain science, aiming to advance early screening, treatment, and rehabilitation management for major conditions such as stroke, cognitive impairment, and depression.